Importantly, western blot analysis revealed a marked decrease in ac-K310 levels in postmortem brain tissues of AD patients compared to controls, while total TFEB levels remained unchanged (Fig. 9A, B). The gene discussed is TFEB; the disease is Alzheimer disease.